RAPAFUSYN
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 03 May 2023)
What this means for you
Registered since 25 Jul 2017. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 86775141
- Registration number
- 5251736
- Mark type
- Stylized text
- Filed
- 01 Oct 2015
- Published for opposition
- 01 Mar 2016
- Registered
- 25 Jul 2017
- Attorney of record
- Erik J. Heels
Goods and services
- Class 042 — Scientific and technological services: development of pharmaceutical preparations and medicines; laboratory research services relating to pharmaceuticals; pharmaceutical drug development services; pharmaceutical research and development; pharmaceutical research services
Owner
- Rapafusyn Pharmaceuticals, Inc., Grand Cayman KY1-1106, KY
- Rapafusyn Pharmaceuticals, Inc., Grand Cayman KY1-1104, KY
- Rapafusyn Pharmaceuticals, Inc., Grand Cayman KY1-1104, KY
Prosecution history
- 03 May 2023 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 03 May 2023 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 03 May 2023 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 22 Oct 2022 — TEAS SECTION 8 & 15 RECEIVED
- 25 Jul 2022 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 20 Apr 2021 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 20 Apr 2021 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 20 Apr 2021 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 06 Apr 2021 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 06 Apr 2021 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 06 Apr 2021 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 25 Jul 2017 — REGISTERED-PRINCIPAL REGISTER
- 20 Jun 2017 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 19 Jun 2017 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 02 May 2017 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED